Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma.
Lozano-Calderón SA, Albergo JI, Groot OQ, Merchan NA, El Abiad JM, Salinas V, Gomez Mier LC, Montoya CS, Ferrone ML, Ready JE, Linares FJ, Levin AS, Peleteiro Pensado M, Pozo Kreilinger JJ, Ruiz IB, Ortiz-Cruz EJ, Gebhardt MC, Cote GM, Choy E, Spentzos D, Hung YP, Deshpande V, Chebib IA, McCulloch RA, Farfalli G, Aponte Tinao L, Morris CD, Petur Nielsen G, Anderson ME, Jeys LM.
Lozano-Calderón SA, et al.
Cancer. 2023 Jan 1;129(1):60-70. doi: 10.1002/cncr.34506. Epub 2022 Oct 28.
Cancer. 2023.
PMID: 36305090
Free article.